
    
      This is an efficacy study to test the ability of WR 279,396 topical cream to treat
      uncomplicated cutaneous leishmaniasis caused primarily by Leishmania major in adults and
      children in Tunisia where the disease in endemic. A total of 375 volunteers will be
      randomized to the three arms described above to determine product efficacy. Safety data in
      all three arms will also be collected.
    
  